UNITED STATES
 SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549		 OMB APPROVAL

OMB Number: 3235-0167

Expires: March 31, 2015

Estimated average burden hours per response . . . . . 1.50



FORM 15

CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934.

 

Commission File Number 000-50156  

Molecular Pharmacology (USA) Ltd.		  
(Exact name of registrant as specified in its charter)  

 

284 Oxford Street, Leederville 6007, Perth, Western Australia

 
(Address, including zip code, and telephone number, including area code, of registrant's principal executive offices)  

 

Common Stock

  
(Title of each class of securities covered by this Form)  

 

N/A

  
(Titles of all other classes of securities for which a duty to file reports under section 13(a) or 15(d) remains)  
   

Please place an X in the box(es) to designate the appropriate rule provision(s) relied upon to terminate or suspend the duty to file reports:

 

  
 

Rule 12g-4(a)(1)

Rule 12g-4(a)(2)

Rule 12h-3(b)(1)(i)

Rule 12h-3(b)(1)(ii)

Rule 15d-6

 ■
□
□
□
□		    
   
Approximate number of holders of record as of the certification or notice date: 19
   
Pursuant to the requirements of the Securities Exchange Act of 1934 (Name of registrant as specified in charter) has caused this certification/notice to be signed on its behalf by the undersigned duly authorized person.  

 

 

  
Date: March 5, 2015 By: /s/ Jeffrey Edwards  
      Jeffrey Edwards, Director  
   
Instruction: This form is required by Rules 12g-4, 12h-3 and 15d-6 of the General Rules and Regulations under the Securities Exchange Act of 1934. The registrant shall file with the Commission three copies of Form 15, one of which shall be manually signed. It may be signed by an officer of the registrant, by counsel or by any other duly authorized person. The name and title of the person signing the form shall be typed or printed under the signature.  
                 

 
Molecular Pharmacology (PK) (USOTC:MLPH)
Historical Stock Chart
From Oct 2024 to Nov 2024 Click Here for more Molecular Pharmacology (PK) Charts.
Molecular Pharmacology (PK) (USOTC:MLPH)
Historical Stock Chart
From Nov 2023 to Nov 2024 Click Here for more Molecular Pharmacology (PK) Charts.